Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT
Condition: To Compare Efficacy Intrauterine vs Sublingual MISOPROSTOL in Addition to Oxytocin in Reducing Blood Loss of Post-cesarean Section in High Risk Women Interventions: Drug: sublingual Misoprostol; Drug: Intrauterine Misoprostol Sponsor: Rajavithi Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials